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Background: Despite an increased scientific interest in musical hallucinations over the
past 25 years, treatment protocols are still lacking. This may well be due to the fact that
musical hallucinations have multiple causes, and that published cases are relatively rare.
Objective: To review the effects of published treatment methods for musical
hallucinations.
Methods: A literature search yielded 175 articles discussing a total number of 516
cases, of which 147 articles discussed treatment in 276 individuals. We analyzed the
treatment results in relation to the etiological factor considered responsible for the
mediation of the musical hallucinations, i.e., idiopathic/hypoacusis, psychiatric disorder,
brain lesion, and other pathology, epilepsy or intoxication/pharmacology.
Results: Musical hallucinations can disappear without intervention. When hallucinations
are bearable, patients can be reassured without any other treatment. However, in other
patients musical hallucinations are so disturbing that treatment is indicated. Distinct
etiological groups appear to respond differently to treatment. In the hypoacusis group,
treating the hearing impairment can yield significant improvement and coping strategies
(e.g., more acoustic stimulation) are frequently helpful. Pharmacological treatment
methods can also be successful, with antidepressants being possibly more helpful
than antiepileptics (which are still better than antipsychotics). The limited use of
acetylcholinesterase inhibitors has looked promising. Musical hallucinations occurring
as part of a psychiatric disorder tend to respond well to psychopharmacological
treatments targeting the underlying disorder. Musical hallucinations experienced in the
context of brain injuries and epilepsy tend to respond well to antiepileptics, but their
natural course is often benign, irrespective of any pharmacological treatment. When
intoxication/pharmacology is the main etiological factor, it is important to stop or switch
the causative substance or medication.
Conclusion: Treatments for musical hallucinations tend to yield favorable results when
they target the main etiological factor of these phenomena. There is a need to establish
the natural course of musical hallucinations, their response to non-pharmacological
treatments, and their effects on the patient’s quality of life. There is also a need to
standardize the assessment of treatment responses, and document long-term follow up.
Keywords: Auditory Charles Bonnet syndrome, auditory hallucination, brain lesion, epilepsy,
intoxication/pharmacology, psychiatric disorder
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Introduction
Musical hallucinations (MH) are auditory hallucinations
characterized by songs, tunes, melodies, harmonics, rhythms,
and/or timbres (Coebergh et al., 2009). The scientific interest
in these phenomena has increased significantly over the past
25 years, but so far no evidence-based treatments have been
established. The principle reason for this would seem to be
that published case series are relatively small, and that the
mechanisms responsible for the mediation of MH are probably
diverse. Furthermore, case reports tend to over represent positive
responses, as negative responses to specific medication are rarely
published. We therefore endeavored to identify which treatments
have been tried under which circumstances, and what their effect
has been upon the MH.
MH are commonly divided into two groups. When they
occur without the presence of any associated pathological
abnormalities—with the exception of hearing impairment
(hypoacusis)—they are called idiopathic MH. When there
are associated pathological abnormalities, they are named
symptomatic MH (Coebergh et al., 2009). The most relevant
etiological factors for MH, as reported in the literature,
are brain injuries, epilepsy, psychiatric disorder, and
intoxication/pharmacology (Berrios, 1990; Keshavan et al.,
1992; Evers and Ellger, 2004; Cope and Baguley, 2009).
Research by Fukunishi et al. (1998a), Schakenraad et al. (2006)
and Teunisse and Olde Rikkert (2012) has shown that MH
are more common than previously assumed, with prevalence
rates of 3.6% among groups of patients referred for audiometric
testing. Similar to our own experiences, Ross (1978) and Aziz
(2009) found that after the publication of an article on the
subject several people wrote to them, and told them that
they had adjusted to their MH without seeking any medical
attention. However, others show themselves in dire need of
medical consultation. MH can indeed be experienced as mild and
well-tolerable, but more often they are experienced as severely
disabling, leading to impaired quality of life, significant distress,
and comorbid anxiety and/or depression. Patients often have
difficulty concentrating and falling asleep, and many of them
are afraid that they are dementing or otherwise psychiatrically
ill (Fukunishi et al., 1998b; Cole et al., 2002; Schakenraad
et al., 2006). Occasionally they develop secondary delusions,
and accuse others (frequently neighbors) of being responsible
for the music. As a result, they may even call the police, move
house, or take other drastic measures. Diagnosis and treatment
of such cases is paramount, but at this point the lack of treatment
protocols and our lack of knowledge about the natural history
and prognosis of MH stand in the way of an evidence-based
approach.
Various treatment options have been described in case reports
and modest case series. Non-pharmacological treatment tends
to consist of lifestyle advice, reassurance, and explanation of
the nature of MH, optimization of hearing, and behavioral
modifications [such as listening to actual music (Coebergh et al.,
2009)], but no previous review has recorded the effectiveness of
such interventions. Loneliness may be an important factor and
increasing social interactions and conversations can be beneficial.
All pharmacological treatment of idiopathic MH is off-label. It
tends to consist of antiepileptics, antidepressants, antipsychotics
or acetylcholinesterase inhibitors, but even when treated for a
sufficient amount of time and at adequate plasma levels, MH
can be refractory to most of these treatments (Sacks and Blom,
2012). Repetitive transcranial magnetic stimulation (rTMS) may
perhaps be a viable option in the near future, but so far it only
showed a favorable response in a single medication-resistant
patient with post-traumatic damage to the right temporal lobe
(Cosentino et al., 2010).
This review attempts to quantify the treatment as responses
described in the literature, and to correlate them with the
probable etiology of theMH at hand. It should be noted, however,
that in the literature we reviewed treatment responses were
described and defined in widely varying ways. In some papers
there was an extensive description of what exactly changed in
e.g., the character, loudness and frequency of the MH, whereas
other papers only mentioned that they changed, decreased or
stopped or remained unaltered. Duration and onset of treatment
response were also reported extremely variably and frequently
not mentioned at all.
Methods
For the purpose of this review, we searched the databases
of MEDLINE, psycINFO, and Embase Psychiatry for articles
matching the terms Music∗ hallucin∗, Musical hallucination,
and Treatment, and added relevant papers from our personal
collection with titles such as “Auditory Charles Bonnet
syndrome” and “The sound of silence.” We examined all articles
published between 1890 and January 2015 that were written in
English, Dutch, French or German.
The variables we assessed in each published case report were
age, sex, treatment, and results of treatment. When available,
documentation of hearing impairment, electroencephalography
(EEG), brain imaging, and psychiatric assessment were used
to establish our interpretation of the main etiological factor
(which was occasionally different from that of the original
authors). Five different etiological groups were distinguished
consisting of hypoacusis, brain lesions and other pathology,
epilepsy, psychiatric disorder, and intoxication/pharmacology.
This classification is modeled on Evers and Ellger’s categorization
of MH in 2004 (Evers and Ellger, 2004). When patients had more
than one possible etiology, which turned out to be very common,
we chose the one most closely linked to the onset of the MH.
For example, if a patient with hypoacusis developed a severe
depression, and improved after treatment for depression, then
psychiatric disorder was selected as the main cause of the MH.
However, when the MH were complicated by depression and did
not improve with treatment for depression, than hypoacusis was
selected. In two cases no apparent cause was identified (Duncan
et al., 1989; Satoh et al., 2007).
All cases were subdivided according to kind of treatment, i.e.,
non-pharmacological [rTMS, electroconvulsive therapy (ECT),
ear-nose-throat intervention, cognitive-behavioral therapy
(CBT), coping strategies/explanation], and pharmacological
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[antidepressants, antipsychotics, antiepileptics, other medication
(comprising of benzodiazepines and acetylcholinesterase
inhibitors), and withdrawal of medication]. Furthermore, we
identified cases where the MH decreased or faded away without
any treatment, as well as those where it was documented that
the patient desired no treatment whatsoever (which could be for
multiple reasons, see the Discussion Section).
When MH appeared soon (i.e., within 1 week) after starting
a certain drug or after increasing its dose, and disappeared
soon after stopping or reducing the dose, this medication was
considered themost likely cause; when patients were occasionally
rechallenged and the MH recurred, this was taken as an
extra indication that the medication was causative. However,
standardized measures of causality such as the WHO-UMC
causality assessment system were not applied. At times there
were multiple medications, and at other times the exact time
course of the relation between the intoxication/pharmacological
intervention and MH was unclear.
Epilepsy was deemed the main cause when the MH were
phenomenologically linked to a seizure, e.g., as an aura, ictal
episode or post-ictal episode, when the patient was treated
surgically for an epileptic focus or when epileptiform EEG
abnormalities disappeared which had been present prior to
treatment.
We scored treatment effects in three groups, i.e., “no effect”
(0), “patient experiences a clinically meaningful improvement,
but the hallucinations remain” (1), and “complete disappearance
of the MH” (2). Improvement was deemed meaningful
whenever a report implied that the patient had experienced an
improvement in quality of life; irrespective of whether the MH
were experienced as quieter, less frequent, or not interfering
as much with sleep or daily activities, or whether there was
increased acceptance/insight or improved mood/anxiety. Two
articles (Bergman et al., 2014; Islam et al., 2014) used the Yale-
Brown Obsessive Compulsive Scale (Y-BOCS). At times it was
difficult to rate the exact treatment effects; e.g., Warner and Aziz
(Warner and Aziz, 2005) briefly described 30 patients, mostly
elderly people suffering from hearing loss, and stated that 90%
were treated (among which 23 with antipsychotics). The majority
lost the MH completely, and the remainder reported a reduction
in intensity and frequency of theMH.We chose to conservatively
document this as a single patient with hearing loss treated with
antipsychotics, with a response of 1. Whenever patients had
first tried a certain class of medication without improvement
(0), followed by a positive response to another class (1/2), both
outcomes were scored.
Author JAFC rated the treatment responses in each report. He
is a consultant neurologist who has 9 years of experience with
neurological, psychiatric, neurophysiological, and radiological
diagnosis, and who personally assessed more than 30 patients
experiencing MH. The data were analyzed (and mean treatment
response calculated) in Microsoft Excel for Mac 2011.
Results
A total number of 175 articles were identified that discussed
516 new patients with MH or related symptoms. This collection
of articles included various modest case series [(Fenton and
McRae, 1989;Mahendran, 2007), one which described 44 patients
with MH in association with alcohol hallucinosis (Scott, 1975),
and one which described 55 patients diagnosed with obsessive-
compulsive disorder (OCD) and/or schizophrenia spectrum
disorder where the question was asked whether the patient had
ever heard music that did not have an external origin (other than
humming, thinking of music and simple recollection of music)
(Hermesh et al., 2004)].
Among those 175 articles we found 161 that discussed the
treatment results of MH or related symptoms (including some
which only discussed whether treatment was desired). No more
than 28 of those were published before 1990. We took this as
confirmation of the above-mentioned increase in the scientific
interest in MH over the past 25 years rather than as proof
of any increase in their prevalence. We then excluded all
reports of musical illusions, pseudohallucinations, palinacusis,
hypnagogic or hypnopompic hallucinations, and obsessions (i.e.,
“earworms”); only rarely did our interpretation of obsession vs.
hallucination (i.e., “earworm” vs. MH) differ from that of the
original authors (e.g., Islam et al., 2014). A total number of
276 cases in 147 articles met these inclusion criteria (Colman,
1894; Penfield and Erickson, 1941; David et al., 1944; Mulder
and Daly, 1952; Rozanski and Rosen, 1952; Arieff and Brooks,
1958; Rennie, 1964; Ross et al., 1975; Scott, 1975, 1979; Schiffter
and Straschill, 1977; Miller and Crosby, 1979; Raghuram et al.,
1980; Wieser, 1980; Gilchrist and Kalucy, 1983; Hammeke et al.,
1983; Mackworth-Young, 1983; Aizenberg et al., 1986, 1987,
1991; Jonas, 1986; Cambier et al., 1987; Lanska et al., 1987;
Patel et al., 1987; Keshavan et al., 1988, 1992; Duncan et al.,
1989; Fenton and McRae, 1989; Wengel et al., 1989; Berrios,
1990; McLoughlin, 1990; Donnet and Régis, 1991; Fisman, 1991;
Nevins, 1991; Podoll et al., 1991; Shapiro et al., 1991; Vallada and
Gentil, 1991; Wagner and Gertz, 1991; Freeland and O’Reilly,
1992; Klostermann et al., 1992; Paquier et al., 1992; Erkwoh et al.,
1993; Feehan and Birchwood, 1993; Fénelon et al., 1993; Gilbert,
1993; Inzelberg et al., 1993; Isaacson et al., 1993; Couper, 1994;
Hosty, 1994; Murata et al., 1994; Terao, 1995;Wodarz et al., 1995;
Baurier and Tuca, 1996; Gertz et al., 1996; Stephane and Hsu,
1996; Douen and Bourque, 1997; Marneros et al., 1997; Thorpe,
1997; Clark, 1998; Fernandez and Crowther, 1998; Fukunishi
et al., 1998b, 1999; Terao and Tani, 1998; Baba and Hamada,
1999; Terao and Matsunaga, 1999; Zungu-Dirwayi et al., 1999;
David and Fernandez, 2000; Gomibuchi et al., 2000; Iijima et al.,
2000; Keeley et al., 2000; Schielke et al., 2000; Augustin et al.,
2001; Cerrato et al., 2001; Roberts et al., 2001; Tanriverdi et al.,
2001; Ali, 2002; Curtin and Remund, 2002; Evers et al., 2002;
Izumi et al., 2002; Assal, 2003; Baba et al., 2003; Brusa et al.,
2003; Ginsberg, 2003; Matsui et al., 2003; Moore, 2003; Shinosaki
et al., 2003; Stricker and Winger, 2003; Agrawal and Sherman,
2004; Aziz et al., 2004; Fischer et al., 2004; Hageman et al., 2004;
Kobayashi et al., 2004; Wilkinson and Schuller, 2004; Davies and
Quinn, 2005; Wang, 2005; Biran and Steiner, 2006; Janakiraman
et al., 2006; Gentile et al., 2007; Gilhuis et al., 2007; Mahendran,
2007; Satoh et al., 2007; Tomar and Cheung, 2007; Ukai et al.,
2007; Allen, 2008; Holroyd and Sabeen, 2008; Mocellin et al.,
2008; Umene et al., 2008; Williams et al., 2008; Auffarth and
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Kropp, 2009; Coebergh et al., 2009; Engmann and Reuter, 2009;
Ergün et al., 2009; Rentrop et al., 2009; Strauss and Gertz, 2009;
Tuerlings et al., 2009; Cosentino et al., 2010; Gondim et al., 2010;
Isolan et al., 2010; Kanemura et al., 2010; Mittal and Giron, 2010;
Padala et al., 2010; Shoyama et al., 2010; Wong and Bhalerao,
2010; Bleich-Cohen et al., 2011; Huntley et al., 2011; Bhatt and
de Carpentier, 2012; Calabrò et al., 2012; Johns and Zuromskis,
2012; Ozsarac et al., 2012; Serrador-García et al., 2012; Simões
et al., 2012; Teunisse and Olde Rikkert, 2012; Dinges et al., 2013;
Giermanski et al., 2013; Vitorovic and Biller, 2013; Abdel-Aziz
and Pomeroy, 2014; Aizawa et al., 2014; Bergman et al., 2014;
Colon-Rivera and Oldham, 2014; Futamura et al., 2014; Husain
et al., 2014; Islam et al., 2014; Kataoka and Ueno, 2014; Kumar
et al., 2014; Mansoor and Ganzini, 2014; Woo et al., 2014; Blom
et al., 2015; Joe et al., 2015).
Clinical Features
The clinical features of those 276 cases are shown in Table 1,
and the main etiology in Table 2. Among the cases where sex
was stated, women made up 68.2 % of the population. The
patients’ average age was 63.8 years (range 18–94 years). One
hundred and sixty-six of the patients (60.4%) had a history of
hearing impairment, most of them chronic. The level of hearing
impairment—even whether a hearing aid was required and/or
used, or which frequencies and/or ear were affected—was often
not specified. There was a concomitant psychiatric disorder in
99 (36.2%) of the patients; among them, 69.7% suffered from
mood disorder. Criteria for diagnosing psychiatric disorder were
frequently not recorded, and standardized diagnostic methods
were rarely used.
Treatment Effects
In Table 3 the mean treatment effects per etiology and
pharmacological class are displayed, as well as the number
of patients with a complete response. A mean close to zero
indicates no or little effect of the treatment, and a mean close
to two indicates that the MH disappeared completely or almost
completely.
TABLE 1 | Clinical features of 276 patient with musical hallucinations.
Sex (N = 261) Percentage
Female (N = 178) 68.2%
Male (N = 83) 31.8%
Age (N = 238)
Mean 63.8 year (18–94)
Hearing impairment (N = 166) 60.4%
Psychiatric disorder (N = 99) 36.2%
Depression (N = 52)
Other mood disorder (N = 2)
Schizophrenia spectrum disorder (N = 18)
OCD (N = 4)
Dementia (N = 6)
Anxiety (with or without comorbid depression) (N = 15)
Other (N = 2)
Hypoacusis
In the hypoacusis group, 80 out of 96 patients either received
treatment or improved spontaneously, with a mean effect of
1.19. Twenty-two patients desired no treatment (in two patients
after trying a treatment first) since they generally found that
they could manage without. Although impaired hearing was
considered the main etiological factor, the group had an average
of 1.54 etiological factors. Eleven patients showed spontaneous
improvement, often after reassurance. Behavioral interventions
that were attempted included improving sleep or lying on one
ear at night (which, incidentally, was not helpful during the
day) (Keshavan et al., 1992). Several patients report that they
were bothered less by their MH when they listened to the
radio (Mahendran, 2007; Teunisse and Olde Rikkert, 2012),
drummed along with their fingers (Raghuram et al., 1980), wore
headphones (Keshavan et al., 1988), sang along (Berrios, 1990),
listened to music at bedtime (Coebergh et al., 2009), rubbed
the hair near their ears (Gilchrist and Kalucy, 1983), or used
a tinnitus mask (i.e., a hearing device that delivers music-like
tones) (Abdel-Aziz and Pomeroy, 2014).
Six patients had some response, and six a complete response
to interventions directed at improving their hearing; e.g.,
(optimizing) hearing aids (e.g., Feehan and Birchwood, 1993;
Tuerlings et al., 2009), removing ear wax (Terao and Matsunaga,
1999; Tuerlings et al., 2009), and otosclerosis surgery [which
in one case replaced MH with tinnitus (Mocellin et al., 2008)].
MH occurred only when taking hearing aid out at night in
one patient (Serrador-García et al., 2012). It was generally not
recorded whether changes in the use of a hearing aid made any
difference but several reports mention briefly that no change
occurred. Cochlear implantation can be a cause of MH but in two
cases adaptation of the implant did not lead to any meaningful
improvement (Auffarth and Kropp, 2009; Joe et al., 2015).
Among the 54 patients treated pharmacologically; on average
1.95 types of medication (range 1–11) were tried. The mean
treatment effect of acetylcholinesterase inhibitors was 1.71 in
seven patients (Shinosaki et al., 2003; Ukai et al., 2007; Strauss
and Gertz, 2009; Serrador-García et al., 2012; Colon-Rivera and
Oldham, 2014; Blom et al., 2015). Five other patients were treated
with benzodiazepines or barbiturates and their mean response
was 0.66. The mean treatment effect of antidepressants in 19
patients was 1.0, with six showing a complete response. Themean
treatment effect of antipsychotics in 31 patients was 0.52, with
TABLE 2 | Main etiology.
Main etiology N Percentage (%)
Hypoacusis 96 34.8
Psychiatric disorder 63 22.8
Brain lesion or other pathology 40 14.5
Epilepsy 12 4.4
Intoxication/pharmacology 63 22.8
None of the above 2 0.7
Total 276 100
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TABLE 3 | Mean effect of (pharmacological) treatment on musical
hallucinations (0 = no effect, 1 = clinically meaningful, 2 = complete
disappearance).




Hypoacusis Antipsychotic 0.52 6 (19%) 31
Antiepileptic 0.89 6 (22%) 27
Antidepressant 1 6 (32%) 19
Acetylcholinesterase
inhibitor
1.71 5 (71%) 7
Total response of
all patients
1.19 24 (32%) 76
Psychiatric disorder Antipsychotic 0.75 10 (28%) 36
Antiepileptic 1.18 4 (36%) 11
Antidepressant 1,18 10 (45%) 22
Benzodiazepines 1.00 2 (40%) 5
Psychosis Antipsychotics 1.00 6 (40%) 15
Total 1.26 8 (42%) 19
Depression/Anxiety Antidepressant 1.22 9 (50%) 18
Antipsychotic 0.67 5 (21%) 24
Total 1.32 14 (36%) 39
Total response of
all patients
1.25 31 (49%) 63




1.66 28 (70%) 40
Intoxication/pharmacology Antipsychotic 0 2




1.94 61 (97%) 63
six of them achieving a complete response. The mean treatment
effect of antiepileptics in 27 patients was 0.89, with six achieving
a complete response.
Psychiatric Disorder
Among the group diagnosed with a psychiatric disorder (63
patients) many were treated pharmacologically (54 patients). The
patients had amean response to treatment of 1.25, and an average
of 1.65 causes.
One patient benefited from adjustment of his hearing aid,
even though psychosis was considered the trigger for his MH
(Keshavan et al., 1992). One benefited from singing along (Miller
and Crosby, 1979), one from listening to the radio (Baurier
and Tuca, 1996), and one from CBT (Wilkinson and Schuller,
2004). Four patients improved spontaneously and two did not
want any intervention even thought there were significantly
bothered by their MH (Podoll et al., 1991; Keshavan et al.,
1992). Treating the underlying psychiatric disorder with ECTwas
helpful for MH in five patients, but not in all (Wengel et al.,
1989; Stephane and Hsu, 1996; Janakiraman et al., 2006) and
sometimes the effect was temporary (Colon-Rivera and Oldham,
2014).
The pharmacological treatment response was best when an
antidepressant was used (1.18) (with 10 of them showing a
complete response), or when antiepileptics were used (1.18), with
four patients responding completely. Antipsychotics yielded a
mean treatment response of 0.75, and complete disappearance
of the MH in 10 patients. Results tended to be better
in patients diagnosed with schizophrenia spectrum disorder
(1.00) than in those with mood disorders (0.67). The use
of benzodiazepines led to complete disappearance in two
patients, and to a mean treatment response of 1.0 (in five
patients).
Brain Lesion and Other Pathology
In the brain lesion and other pathology group (40 patients) the
mean number of causes was 1.4 (range 1–3). Sixteen cases of
MH had a cerebrovascular cause, and in nine cases the cause
was a tumor and others had pathology like multiple sclerosis
and Parkinson’s disease. When a tumor was present removal led
to disappearance of MH (Penfield and Erickson, 1941; David
et al., 1944; Scott, 1979). In all stroke cases, the hallucinations
disappeared without any adjuvant treatment in days or months
and up to a year [and in one case only ever lasted 90min
(Cerrato et al., 2001)]. In 22 patients MH disappeared without
intervention.
One patient with a previous head trauma, who had not
responded to antiepileptics and antidepressants, was treated with
rTMS after 1 year of experiencingMH. TheMHdisappeared after
2 weeks, only to reappear after 4 months; although by that time
they were less intense, and only present in a quiet environment
and before falling asleep (Cosentino et al., 2010).
All in all it is difficult to fully ascertain any medication
effects in the brain injury group. Thirteen patients were treated
pharmacologically, but in one case of delirium (Rentrop et al.,
2009) and in two cases of brain tumor patients the natural
history probably led to improvement (Evers et al., 2002), rather
than the use of medication (i.e., olanzapine and pregabalin,
respectively). Four patients showed a complete response, and
three no response to antiepileptics; three patients were treated
with antidepressants, and four with antipsychotics, which are
all very small numbers to establish a mean treatment response.
Twenty-two improved spontaneously and six did not want any
treatment.
Epilepsy
The rather small epilepsy group, which comprised of 12 patients,
had a mean treatment response of 1.66. The mean number of
medication used was 1.08 (range 1–4) in eight patients. MH
tended to respond well to antiepileptics or surgery for the
underlying cause (Rennie, 1964; Wieser, 1980; Roberts et al.,
2001). Four cases of MH resolved spontaneously and were ictal
or post-ictal in nature, and some of these patients were on
antiepileptics already that was not changed or just started after
the seizure but the MH were in all likelihood post-ictal.
Intoxication/Pharmacology
The intoxication/pharmacology group comprised of 63 patients.
The mean treatment result was a robust 1.94 when patients
stopped their medication or switched to another type of
medication.When the above-mentioned case series of 44 patients
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with alcoholic hallucinosis (Scott, 1975) was excluded, the mean
treatment response was 1.79. The mean number of causes in the
intoxication/pharmacology group was 1.4.
They include benzodiazepines [lormetazepam (Ginsberg,
2003), temazepam (Fisman, 1991), lorazepam (Curtin and
Remund, 2002), and triazolam (Nevins, 1991)], opioids
[morphine (Davies and Quinn, 2005), tramadol (Keeley et al.,
2000) and oxycodone (Moore, 2003)], tricyclic antidepressants
[imipramine (Terao, 1995), clomipramine (Vallada and Gentil,
1991) and mirtazapine (Padala et al., 2010)], anticholinergic
medication [biperiden (Gertz et al., 1996)], alcohol (Scott, 1975),
an N-methyl-D-aspartate antagonist [amantadine (Gondim
et al., 2010)], a dopamine agonist [bromocriptine (Kobayashi
et al., 2004)], salicylates (Allen, 2008), dipyridamole(Tomar
and Cheung, 2007), propranolol (Fernandez and Crowther,
1998), voriconazole (Agrawal and Sherman, 2004), pentoxifylline
(Gilbert, 1993) and steroids (Kanemura et al., 2010).
Only six patients in this group were treated with adjuvant
medication. This had no effect, except in one patient who
suffered from depression, white matter changes and a hearing
impairment. Biperiden induced the MH and they responded to
carbamazepine (Gertz et al., 1996). One patient benefited from
listening to the radio (Fernandez and Crowther, 1998).
In 42 cases the musical hallucinations decreased or
disappeared without any treatment—see Table 4. As indicated
above, most of them stemmed from the brain lesion and other
pathology group.
Discussion
Musical hallucinations, like actual musical sounds, are associated
with activity in an extensive network of interconnected brain
areas. This network comprises auditory areas, visual areas, basal
ganglia, brainstem, pons, tegmentum, cerebellum, hippocampi,
amygdala, motor cortex, the peripheral auditory system, and
possibly many other areas (Sacks and Blom, 2012). Even though
there is not a single unique pathophysiological pathway within
the network that can be held responsible for the mediation of
MH, there is often an etiological factor that would seem to act as a
necessary and sufficient condition for it to become activated. We
hypothesized that the key to successful treatment of MH might
lie in identifying that etiological factor. Based on our analysis of
the treatment results of 276 patients with MH as described in the
literature, the following can be said about this.









In the hypoacusis group—with patients suffering from
idiopathic MH—frequently no treatment is required except for
explanation, behavioral interventions, and improving auditory
function. And yet pharmacological therapy can also be successful,
with many different medications. The mean treatment response
rate in this group is highest—although admittedly modest—with
acetylcholinesterase inhibitors, followed by antiepileptics and
antidepressants, and lowest with antipsychotics (which however
can still be useful). Symptomatic MH, on the other hand, are
more likely to respond to pharmacological treatment. In the
group diagnosed with a psychiatric disorder, the type of disorder
provides the most important clue to choice of treatment. Thus,
treating MH experienced in the context of a depression with
the aid of an antidepressant is more effective than with an
antipsychotic, whereas MH experienced in the context of a
schizophrenia spectrum disorder tend to respond more often to
antipsychotics. Patients in the brain-injury and epilepsy groups
can best be treated with antiepileptics, although in these groups
the natural course of the MH is often benign, especially after a
stroke. When intoxication/pharmacology is the main etiological
factor, it is important to stop the medication that is held
responsible for their mediation, and if necessary to replace it with
a substance from a different pharmacological class.
As an aside, it is worth mentioning that in the
intoxication/pharmacology group many causative medications
play a role that have an opposite effect to medications
used for treatment. Dopamine agonists (causative) and
antipsychotics (treatment) work on the same dopaminergic
receptors. Anticholinergics and tricyclics (causative) and
acetylcholinesterase inhibitors (treatment) act on the same
cholinergic neurotransmitters. Benzodiazepines, which act on
the gamma-amino-butyric-acid (GABA) system, can at once be
causative and curative. This suggests that all the neurotransmitter
systems and receptors involved can play an a priori unpredictable
role in the mediation and treatment of MH, and that proper
clinical and pharmacological assessment is always necessary to
establish the course of action that is most likely to yield favorable
results.
Limitations
This review has several limitations. Firstly, there would seem
to be a positive publication bias for successful treatments. For
example, salicylates (Allen, 2008) and propranolol (Fernandez
and Crowther, 1998), which in some studies are associated
with the mediation of MH, are used by many of our patients
in clinical practice without causing this particular side effect.
Moreover, we have attempted to treat some of our patients by
withdrawing these medications, and no resolution of the MH
was ever noted. None of the pharmacological treatments (or
withdrawal) were ever placebo controlled. There may also be a
positive publication bias for pharmacological treatments per se.
Many of our patients, after proper explanation, prefer not to try
any medication, whereas others try one type of medication but
refrain from trying another type. In our experience some patients
are content with explanation and practical advice, which is also
described by others (Shapiro et al., 1991; Feehan and Birchwood,
1993; Bhatt and de Carpentier, 2012; Johns and Zuromskis,
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2012; Teunisse and Olde Rikkert, 2012). However, the fact that
patients show themselves content without any pharmacological
intervention does not mean that no treatment should be offered
(Podoll et al., 1991; Keshavan et al., 1992).
A second limitation of this review is that its sample size is
relatively small (N = 276), especially when subdividing the
group in etiological subgroups. A previous review included 132
patients (Evers and Ellger, 2004), and yet another one did not
state the total number of patients included but instead based its
conclusions on 55 relevant papers (Cope and Baguley, 2009). Our
sample size is nevertheless the largest analyzed so far. With the
small numbers involved it cannot be ruled out that the variations
are due to chance since statistical significance of differential
treatment responses in every etiological subgroup would often
not have been reached.
Thirdly, we may have underestimated the effects of
antipsychotics in the hypoacusis group by not including
the majority of patients described byWarner and Aziz (2005). As
noted above, we decided to count this group as a single patient
because individual patient data were lacking in the original
report. However, the mean response rate to antipsychotics
in this study is much higher than in others. Moreover, by
lumping various classes of antidepressants into a single group,
we may have missed the opportunity to identify possible group
differences, especially since tricyclics are implicated in various
studies as possible causes of MH. The same holds true for the
various groups of antipsychotics and antiepileptics that work on
very different ion channels and neurotransmitters.
If patients have tried multiple drugs in one class but did
respond to another one we scored this as a response and therefore
overestimated the effect of individual drugs; some patients tried
up to 11 medications (Colon-Rivera and Oldham, 2014).
The interpretation of the intoxication/pharmacology
literature is influenced by inclusion of 44 patients with alcoholic
musical hallucinosis out of a total of 63 patients (Scott, 1975).
Removing them from the analysis did not alter the finding
that withdrawing the presumed offending medication is highly
effective.
Conclusions and Recommendations
Musical hallucinations are best treated by directing our
intervention at the etiological mechanism responsible for
their mediation. Based on the findings presented above and
on our clinical experience with MH, our advice would be
to chart the (possibly multiple) underlying causes with the
aid of a history; extensively exploring temporal relationships
between MH and medication, trauma, drug (ab-)use, seizures,
and use of hearing aid devices. Furthermore, neurological
assessment, psychiatric assessment an ear, nose, and throat
(ENT) assessment are recommended, and imaging with an
MRI head. Not all patients need treatment, as MH may be
self-limiting, especially when occurring after brain lesions. If
associated distress is low, reassurance may be enough. When
treatment is indicated, we suggest that non-pharmacological
interventions should be attempted first. This may involve
interventions ranging from behavioral modifications, increasing
social interactions and CBT. ENT interventions and withdrawing
possible causative medication should be attempted due to their
low risk of side effects. When idiopathic MH significantly
affects the patient’s quality of life, it is worthwhile to target any
particularly troublesome symptom, i.e., anxiety with a selective
serotonin reuptake inhibitor (SSRI), a secondary delusion with
antipsychotics, and sleep disturbances with hypnotics. In the
hypoacusis group, pharmacological treatment can first perhaps
best be attempted with acetylcholinesterase inhibitors. Although
there currently is only limited evidence for the effectiveness of
this medication group, in our clinical experience they can help
significantly, while side effects are relatively mild as compared to
antipsychotic and antiepileptic medication.
Antidepressants and antiepileptics have a more favorable
response rate and less side effects than antipsychotics;
considering most patients are elderly. The literature documents
several examples of beneficial effects using carbamazepine, often
a low doses.
Targeting treatment to the underlying psychiatric disorder can
clearly be helpful; MH in those with mood disorders respond less
well to antipsychotics than in those with a psychotic disorder.
ECT can clearly be helpful in patients with severe depression and
MH (Wengel et al., 1989; Stephane and Hsu, 1996; Janakiraman
et al., 2006), albeit sometimes relief of MH is only brief (Colon-
Rivera and Oldham, 2014).
Further exploration of rTMS could be worthwhile after the
successful treatment in a very treatment resistant case (Cosentino
et al., 2010).
Finally, we would like to make recommendations for further
research. There ought to be a clear documentation of the volume
and frequency of the MH, degree of control over the MH,
quality of the MH (as well as its relation to tinnitus), and the
influence of MH on daily life, before and after the start of
treatment. Documenting what is taken as a successful treatment
response (i.e., less meaningful, less frequent/intrusive/loud,
more control, complete disappearance, improved sleep) is also
essential. It should be considered to try placebo-controlled
treatment (and withdrawal of presumed offending medication).
Larger sized treatment trials should be able to elucidate whether
the differential treatment response to different (classes) of
medication is real, as suggested by this review. This should allow
for a more effective and accurate assessment of the effects of
treatment in the future. Perhaps, analogous to recent initiatives
to create international databases for rare diseases, a database for
cases of MH should be considered, with a focus on diagnostic
findings, natural course, and treatment results.
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